Clinical trial
O(6)-Benzylguanine and Carmustine in Treating Patients With Solid Tumors
NCT00002604 · Case Comprehensive Cancer Center, Other · Completed
Key facts
| NCT number | NCT00002604 |
|---|---|
| Title | O(6)-Benzylguanine and Carmustine in Treating Patients With Solid Tumors |
| Official title | Phase I Trial of O6 Benzylguanine and BCNU; A Biochemical Modulation Trial Based Upon Depletion of O6 Alkylguanine DNA Alkyltransferase Directed DNA Repair |
| Lead sponsor | Case Comprehensive Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Unspecified Adult Solid Tumor, Protocol Specific |
| Intervention type | Drug |
| Interventions | O6-benzylguanine, carmustine, chemosensitization/potentiation therapy |
| Enrollment | 28 |
| Start date | Jan 1, 1996 |
| Primary completion | Jul 1, 2000 |
| Completion | Feb 1, 2004 |
| First posted | Jul 29, 2004 |
| Last update posted | Jul 8, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: